Canada’s Altachem Pharma is currently in advanced negotiations with an international disinfectant distribution company for the Saudi Arabian market. The company recently converted its Beijing Erdos Altachem Pharma joint venture into a wholly owned foreign company.
The Corporation is developing a multi-tiered, integrated approach for the treatment of HIV/AIDS and cancer using non-toxic therapeutic products and adjunct therapies. The products of the corporation are based on its two proprietary drugs: ACP-HIP and HB. The Corporation's manufacturing facilities located in Edmonton, Alberta and Shanghai. — (menareport.com)
© 2003 Mena Report (www.menareport.com)
